Mannan-binding lectin serine protease: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) New page: <StructureSection load='5jpm' size='340' side='right' caption='Caption for this structure' scene=''> == Function == '''Mannan-binding lectin serine protease''' (MASP) are proteases asso... |
Michal Harel (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
<StructureSection load='5jpm' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='5jpm' size='340' side='right' caption='Caption for this structure' scene=''> | ||
Line 25: | Line 24: | ||
**[[3gov]] – hMASP-1 chain A sushi domain, chain B catalytic domain <br /> | **[[3gov]] – hMASP-1 chain A sushi domain, chain B catalytic domain <br /> | ||
**[[3pob]] – rMASP-1 CUB2 domain + MBL collagen-like peptide - rat <br /> | **[[3pob]] – rMASP-1 CUB2 domain + MBL collagen-like peptide - rat <br /> | ||
**[[3poe]], [[3pof]], [[3pog]], [[ | **[[3poe]], [[3pof]], [[3pog]], [[3poi]], [[3poj]] – rMASP-1 CUB2 domain <br /> | ||
*Mannan-building serine protease 2 | *Mannan-building serine protease 2 |
Revision as of 11:01, 20 December 2016
FunctionMannan-binding lectin serine protease (MASP) are proteases associated with mannan-binding lectin (MLB). The lectin pathway of complement is part of the innate immunity. The pathway activation occurs via recognition of pathogens by MBL followed by activation of MASP leading to activation of the complement system[1]. DiseaseRelevanceStructural highlights |
|
3D structures of mannan-binding lectin serine protease3D structures of mannan-binding lectin serine protease
Updated on 20-December-2016
ReferencesReferences
- ↑ Thiel S, Jensen L, Degn SE, Nielsen HJ, Gal P, Dobo J, Jensenius JC. Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components. Clin Exp Immunol. 2012 Jul;169(1):38-48. doi: 10.1111/j.1365-2249.2012.04584.x. PMID:22670777 doi:http://dx.doi.org/10.1111/j.1365-2249.2012.04584.x